News Search Results
Jul 22, 2025, 03:52 ET METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting
nonprofit scientific organization dedicated to advanced drug delivery. At this year's meeting, METiS Technologies stood out as the only Chinese biotechnology company participating with a featured poster presentation. Dr. Hongming Chen, Co-founder and Chief R&D Officer
More news about: METiS Technologies
Jul 22, 2025, 03:00 ET SkylineDx's Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study
www.merlinmelanomatest.com. About SkylineDx SkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology inflammatory, and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Jul 22, 2025, 01:48 ET Vicebio, next-generation vaccine biotech, to be acquired by Sanofi for US$1.6 billion
New York City, with over $6.5 billion in capital primarily focused on supporting emerging life sciences and biotechnology companies. For more information, please visit:
More news about: Vicebio
Jul 21, 2025, 16:05 ET Tyra Biosciences Announces Fireside Chat on Achondroplasia and Growth Disorders at UBS Biotech Management Live Call Series
July 21, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Jul 21, 2025, 15:45 ET AusperBio Receives China CDE Clearance to Advance AHB-137 into Phase III Clinical Trial for Chronic Hepatitis B
2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, today announced that the China Center for Drug
More news about: AusperBio Therapeutics Inc.
Jul 21, 2025, 11:31 ET Nanotechnology in Agriculture Market Size to Grow USD 6743.3 Million by 2030 with a CAGR of 12.7% | Valuates Reports
efficiency, and food security, stakeholders across academia, government, and industry are collaborating to advance adoption. The convergence of biotechnology, smart systems, and material science is expected to propel the market forward. As barriers to scalability and regulation continue to ease, nanotechnology
More news about: Valuates Reports
Jul 21, 2025, 11:30 ET Electronic Data Interchange Market Size to Grow USD 74.36 billion by 2031, Rising Digital Transformation Across Various Industries Propels | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 21, 2025, 11:00 ET Oil Country Tubular Goods Market Size to Grow by USD 37.26 billion by 2031, Growth Due to Increasing Oil & Gas Exploration and Production (E&P) Activities | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 21, 2025, 10:01 ET Healthcare Consulting Services Market Worth $51.95 Billion by 2030 with 10.1% CAGR | MarketsandMarkets™
Asia Pacific region is expected to grow at the highest rate during the forecast period. This region has numerous pharmaceutical and biotechnology companies that utilize healthcare consulting services. The rapid digital transformation, government healthcare reforms, rising healthcare spending,
More news about: MarketsandMarkets
Jul 21, 2025, 08:33 ET GlycoNex to Participate in BIO Asia-Taiwan 2025
GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced its participation in the 2025 BIO Asia-Taiwan International
More news about: GlycoNex, Inc.
Jul 21, 2025, 06:00 ET IDEAYA Biosciences to Participate in Upcoming July 2025 Investor Relations Event
BTIG Virtual Biotechnology ConferenceTuesday, July 29th, 2025 at 4:40 PM ET Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Justin Zelin, Director, Biotechnology Research AnalystA
More news about: IDEAYA Biosciences, Inc.
Jul 21, 2025, 02:43 ET BPC Instruments receives order from Cornell University of 1 MSEK
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Jul 20, 2025, 22:54 ET CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services
GLP-certified preclinical CRO based in South Korea, has entered into a strategic partnership with ATG Lifetech, a biotechnology company specializing in transcriptome analytics and organoid-based modeling. This collaboration aims to deliver next-generation, precision-driven
More news about: CorestemChemon Inc.
Jul 18, 2025, 16:15 ET Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
July 18, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced that it received a notice from The Nasdaq Stock
More news about: Virax BioLabs Group Limited
Jul 18, 2025, 11:15 ET Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR of 4.3% | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 18, 2025, 10:45 ET Technetium-99m Market Size to Reach USD 6.29 Billion by 2031, Growing at a CAGR of 3.9% | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
More news about: The Insight Partners
Jul 17, 2025, 18:45 ET Human Longevity, Inc. Expands $1 Million Cancer Prevention Pledge to Safeguard Against Late-Stage Ovarian Cancer
ensuring its members benefit from the most advanced tools available. About Human Longevity, Inc.Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, AI, and multimodal diagnostics to extend human healthspan. Through its flagship Executive Health
More news about: Human Longevity, Inc.
Jul 17, 2025, 12:20 ET Nonwoven Filter Media: A Global Market Analysis and Future Forecast
ultrafiltration membranes market, segmented by material type, membrane type, and end use. It focuses on industrial applications across sectors like biotechnology, pharmaceuticals, potable water, wastewater, and food and beverages. The study examines market dynamics, trends, pricing, and strategies, along
More news about: BCC Research LLC
Jul 17, 2025, 11:15 ET Patient-Derived Xenograft Model Market Size at USD 1.12 Billion in 2031, Forecasted to Grow at 13.4% CAGR Through 2031 | The Insight Partners
xenograft model market in 2024.In terms of end user, the patient-derived xenograft model market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, and CROs. The academic & research institutions segment held the largest share of the patient-derived
More news about: The Insight Partners
Jul 17, 2025, 11:00 ET Advanced Distributed Management System Market Size expected to reach US$9.36 Billion by 2031, Exhibiting a CAGR of 16.6% | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
More news about: The Insight Partners
Jul 17, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP
Jul 17, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jul 17, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Jul 17, 2025, 07:00 ET NLS Pharmaceutics Highlights Continued Progress in iTOL-102 Diabetes Program as BIRD Foundation Approves Additional Milestone Payment to Kadimastem and iTolerance for Continued Co-Development of Type 1 Diabetes Cell Therapy
solutions for NT1, including potential cell therapy approaches. About Kadimastem Kadimastem Ltd. (TASE: KDST) is a clinical-stage biotechnology company developing and manufacturing allogeneic, "off-the-shelf" cell therapies derived from human embryonic stem cells (hESCs). The company's lead
More news about: NLS Pharmaceutics Ltd.
Jul 17, 2025, 02:30 ET One Biosciences Announces €15 Million Series A Financing to Advance Clinical Single Cell Profiling
selection, therapy development, and optimize clinical trialsProceeds will also help scale strategic partnerships with pharmaceutical and biotechnology companiesFinancing led by Redmile Group and Blast, with participation from Galion.exe, Invus, Adamed Technology, Sofinnova Partners,
More news about: One Biosciences